The current findings of the hepatoprotective effects of CM associated with the increased PPAR-α and CPT1A protein levels coincide with similar results in the NAFLD mice treated with the natural sweetener stevioside extracted from the medicinal plant S. rebaudiana Bertoni. The gene discussed is CPT1A; the disease is metabolic dysfunction-associated steatotic liver disease.